Home/Filings/4/0001069530-21-000016
4//SEC Filing

FRIEDMANN NADAV 4

Accession 0001069530-21-000016

CIK 0001069530other

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 4:06 PM ET

Size

8.4 KB

Accession

0001069530-21-000016

Insider Transaction Report

Form 4
Period: 2021-03-17
FRIEDMANN NADAV
DirectorChief Operating Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2021-03-17$53.55/sh+28,015$1,500,20392,428 total
  • Exercise/Conversion

    Common Stock

    2021-03-17$53.55/sh28,015$1,500,2030 total
    Exercise: $53.55From: 2015-06-01Exp: 2021-06-01Common Stock (28,015 underlying)
  • Tax Payment

    Common Stock

    2021-03-17$62.52/sh23,996$1,500,23068,429 total
Footnotes (1)
  • [F1]Form 4 represents net exercise of stock options only. No shares of common stock were sold to third parties in this transaction.

Issuer

CASSAVA SCIENCES INC

CIK 0001069530

Entity typeother

Related Parties

1
  • filerCIK 0001245267

Filing Metadata

Form type
4
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 4:06 PM ET
Size
8.4 KB